Journal Watch - Soy Isoflavones
-
Soy Isoflavones Reduce Heart Disease Risk Factors in PD
A trial randomly assigned 40 PD patients to a soy isoflavone or placebo group, and took several measures of inflammation at baseline and 8 weeks. At the end of the study, those in the soy group had significant decreases in serum VCAM-1 and serum ICAM-1, two cardiovascular disease risk factors in PD patients
Read the abstract » | (added 2020-06-10)